Cargando…
The global landscape of approved antibody therapies
Antibody therapies have become an important class of therapeutics in recent years as they have exhibited outstanding efficacy and safety in the treatment of several major diseases including cancers, immune-related diseases, infectious disease and hematological disease. There has been significant pro...
Autores principales: | Lyu, Xiaochen, Zhao, Qichao, Hui, Julia, Wang, Tiffany, Lin, Mengyi, Wang, Keying, Zhang, Jialing, Shentu, Jiaqian, Dalby, Paul A, Zhang, Hongyu, Liu, Bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9535261/ https://www.ncbi.nlm.nih.gov/pubmed/36213257 http://dx.doi.org/10.1093/abt/tbac021 |
Ejemplares similares
-
GENERATION OF NOVEL ANTIBODY CANDIDATES USING TRANSFORMER AND GAN-BASED DEEP LEARNING ARTIFICIAL INTELLIGENCE
por: Zhang, Hongyu, et al.
Publicado: (2023) -
Stability
Convergence in Antibody Coformulations
por: Zhang, Hongyu, et al.
Publicado: (2022) -
Current landscape of clinical development and approval of advanced therapies
por: Iglesias-Lopez, Carolina, et al.
Publicado: (2021) -
Monoclonal Antibodies Approved for Cancer Therapy
por: Baldo, Brian A.
Publicado: (2016) -
Investigating the landscape of US orphan product approvals
por: Miller, Kathleen L., et al.
Publicado: (2018)